Disease

News Hour: Novo Nordisk announced a four-year extension of its Changing Diabetes® in Children programme which provides access to diabetes care and free insulin to children with type 1 diabetes in developing countries. The expansion sees...

News Hour: The birth of a new baby is a joyous time for most families.  For those born prematurely, however, this period can be very dangerous.  Premature babies do not have fully formed lungs, and they...

News Hour: Tresiba® is a once-daily basal insulin that provides a duration of action beyond 42 hours. It is important for people with type 1 and type 2 diabetes to establish a routine for insulin treatment....

News Hour: Estimates for 2015 suggest that 5.9 million children worldwide died before reaching the age of five, including 2.7 million newborns. Globally, four million (4.02 million) fewer child deaths occurred in 2015 than in 2000,...

News Hour: Scientists have identified genetic markers associated with resistance to the one of the most commonly used malaria drugs in Southeast Asia. The findings of two independent studies from Cambodia, published in The Lancet Infectious...

News Hour: At the Closing Ceremony of the 47th Union World Conference on Lung Health, José Luis Castro, The Union’s Executive Director, paid tribute to Dr Anthony Harries as he steps aside from his role as...

News Hour: The innovation needed to maintain tuberculosis (TB) treatment and care in the face of natural disasters and weak health systems. Studies conducted on TB interventions implemented in the wake of the 2010 Haiti earthquake...

News Hour: A total of 85,000 people including 35,000 children in the poor, rural county of Xingtang, China, will be screened for preventable eye disease as part of a two-year project to reduce avoidable blindness and...

News Hour: A possible cluster of cases of acute flaccid myelitis, a rare condition that causes weakness or paralysis in children, is being investigated in King County, Washington, the state health department said on Tuesday. King...

Sanofi and its vaccines global business unit Sanofi Pasteur, announced today that it has agreed to Principles of Collaboration with the Oswaldo Cruz Foundation– by means of its Immuno-biological Technology Institute known as Bio-Manguinhos/Fiocruz-and the Walter...